Clinical trials: Hyperlipoproteinemia (a)

Hypercholesterolemia, Mixed Hyperlipemia

MK0859 Dose-Ranging Study (0859-003)

• Terminated
• Age: 18 to 75 years
• Phase 2

To assess the cholesterol changing effects of MK0859 in patients with primary hypercholesterolemia or mixed dyslipidemia.

Trial name

NCT00325455

Testing

MK0859

Volunteers

500 people

Sponsor

Merck Sharp & Dohme LLC